Medlab Group PTY LTD was spun out of the Medlab Clinical Limited Company at the Dec 2023 General Meeting by shareholder resolution.

Medlab Group PTY LTD owns Medlab IP PTY LTD and Medlab Clinical US Inc. The main business activity of Medlab Group PTY LTD is to commercialise via out-licencing the intellectual property held in both Medlab IP PTY LTD and Medlab Clinical US Inc.

Whilst there are many different Medlab-named companies, the Medlab Group PTY LTD is not connected to any other Medlab organisations owned by 3rd parties.

The former company, Medlab Clinical Limited is (at the time of writing) a public biotechnology company that was embarking on the development of new pharmaceutical products subject to various regulatory approvals such as the US FDA. The former company, Medlab Clinical Limited is expected to restructure subject to another/future general meeting.

Medlab Group PTY LTD is not continuing drug development work, instead, it is out-licencing the technologies to interested 3rd parties.

Out-licensing, is when a company (the licensor) grants another organization (the licensee) the rights to use its product, technology, or intellectual property. In this case, the licensor typically receives royalties, upfront fees, or milestone payments from the licensee.

Yes, we endeavour to make “partnering” as seamless and efficient as possible, read about our key elements here.

No. We don’t sell or market products, we licence technologies that an organisation like a pharmaceutical, nutraceutical, cosmetic or food company may incorporate into their range of products.

No. Some time ago, under Medlab Clinical Limited, the then company sold off the Australian rights for select nutraceuticals to a company called Pharmacare, owners of the Bioglan brand. The Pharmacare agreement pre-dates the General Meeting in Dec 2023 which created Medlab Group PTY LTD. Pharmacare has the rights to use NanoCelle in select nutraceuticals, D3 and B12 being an example.

As per resolutions of the Dec 2023 EGM (ASX:MDC) if you where a security holder as at the record date of 12 JAN 2024, you become a Royalty holder of Medlab Group until 12 JAN 2028. Please refer to the Dec 2023 EGM reading pack and outcomes for specifics.

Unless you had securities in ASX:MDC as at the 12 Jan 2024, to can’t.